Poisons List Amendment Order 2011


Tasmanian Crest
Poisons List Amendment Order 2011

I make the following order under section 15(1) of the Poisons Act 1971 .

23 May 2011

MICHELLE O'BYRNE

Minister for Health

1.   Short title

This order may be cited as the Poisons List Amendment Order 2011 .

2.   Commencement

This order takes effect on the day on which its making is notified in the Gazette or on 1 June 2011, whichever is later.

3.   Principal Order

In this order, the Poisons List Order 2001 is referred to as the Principal Order.

4.    Schedule 2 amended (Medicinal Poisons)

Schedule 2 to the Principal Order is amended by inserting after item 2088M the following item:

2089. 

Mercurochrome in preparations for external use containing 2% or less of mercurochrome.

5.    Schedule 4 amended (Restricted Substances)

Schedule 4 to the Principal Order is amended as follows:
(a) by omitting item 40471 and substituting the following:

40471. 

Diclofenac except –

 

(a) when included in Schedule 2 or 3 ; or

 

(b) in preparations for dermal use unless –

 

(i) for the treatment of solar keratosis; or

 

(ii) containing more than 1% of diclofenac.

(b) by inserting after item 40934 the following:

40934M. 

Mercurochrome except when included in Schedule 2 or 6 .

(c) by inserting after item 41106 the following:

41106M. 

Ofatumumab.

(d) by inserting after item 41338K the following:

41338L. 

Rilpivirine.

(e) by inserting after item 41546 the following:

41546M. 

Tolvaptan.

(f) by inserting after item 41624 the following:

41624M. 

Vinflunine.

Displayed and numbered in accordance with the Rules Publication Act 1953.

Notified in the Gazette on 1 June 2011

This order is administered in the Department of Health and Human Services.

EXPLANATORY NOTE

(This note is not part of the order)

This order amends the Poisons List Order 2001 by incorporating changes recommended by the National Drugs and Poisons Schedule Committee in the Standard for the Uniform Scheduling of Medicines and Poisons No. 1, Amendment No. 2.